A few weeks ago, I spoke how interim CEOs often cook the books– so they can be permanently appointed. That happens to be a marginally (or fully) criminal endeavor. But, many, many other CEOs obfuscate results so that their stock price stays high- and that often sets their (ridiculously high) compensation levels.
Tag Archives: Valeant
Pharma Merger Season?
We talked about Pfizer and AstraZeneca in the first part of this mini-series. A merger that is less about what is good for the pharmaceutical offerings of both firms than it is a means to exploit holes in the tax codes of various nations.